ADMA BIOLOGICS, INC.
For the period ended Dec 31, 2025. Filed Feb 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 25, 2026
ADMA$12.73-3.6%Stored close · as of Nov 6, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingComparison unavailable
The comparison is taking longer than usual or could not load. Reload to try again, or open the filing text.
Unavailable is not the same as unchanged.